Awewura Kwara is an Infectious Disease physician affiliated with University of Florida. OpenAlex indexes 127 publications with 2,328 citations (h-index 30); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Box 100371
Gainesville, FL 326100371
Telephone
352-265-0301Registry record last updated 16 Aug 2016.
Clinical trials
- Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection
Sponsor: University of Florida
- Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents
Sponsor: University of Florida
- Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor55.2%Tivicay100%Part D<11 patientsShort-acting sulfonamides44.8%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Addressing Research Gaps to Optimize Dolutegravir-based ART in Children and Adolescents
University of Florida
FY2026$539,837R01AI186847 - Addressing Research Gaps to Optimize Dolutegravir-based ART in Children and Adolescents
University of Florida
FY2026$139,260R01AI186847 - Addressing Research Gaps to Optimize Dolutegravir-based ART in Children and Adolescents
University of Florida
FY2025$466,515R01AI186847
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children
The International Journal of Tuberculosis and Lung Disease
2021 - In-Clinic Adolescent Peer Group Support for Engagement in Sub-Saharan Africa: A Feasibility and Acceptability Trial
Journal of the International Association of Providers of AIDS Care (JIAPAC)
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida
Brian Hoh, MD
University of Florida
Frederic Kaye, MD
University of Florida
Kelly Foote, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”